• Investors




Novo Holdings, the holding company in the Novo Group, is responsible for the management of the assets of the Novo Nordisk Foundation, which are currently valued at more than DKK 300 billion.

Novo Holdings is a private limited liability company fully owned by the Novo Nordisk Foundation.

Besides being the major shareholder in the Novo Group companies, Novo Holdings provides seed and venture capital to development stage companies and takes significant ownership positions in well-established companies, within life science, as well as manages a broad portfolio of financial assets.

For further information visit www.novo.dk



As the majority shareholder in three large Danish companies, Lundbeck, Falck and ALK-Abelló, Lundbeckfonden is one of the largest, industrial foundations in Denmark. In 2015, the market value of the foundation’s commercial activities amounted to close to DKK 50 billion including a portfolio of internally managed securities of about DKK 15 billion. In addition to this, the foundation manages a portfolio of more than 20 life science investments. Lundbeckfond Emerge is the early stage investment unit of the foundation.

With a primary focus on brain health, Lundbeckfonden annually grants DKK 400 - 500 million to support biomedical research of the highest, international quality as part of the foundation’s vision to create better lives through new knowledge.

For further information visit www.lundbeckfonden.com


Sunstone Capital is an independent venture capital investor founded in 2007 by an international team of industry experts with combined entrepreneurial, operational and financial experience. Sunstone Capital focuses on developing and expanding early-stage Life Science and Technology companies with strong potential to achieve global success in their markets. Sunstone Capital currently manages four Life Science funds and three Technology funds. Within Life Science, Sunstone Life Science Ventures has invested in more than 35 companies in the areas of pharmaceuticals, medical technologies and diagnostics, and has completed several successful exits and IPOs. Managing total funds of EUR 693 million, Sunstone Capital is one of the largest and most active European venture capital investors.

For further information visit www.sunstone.eu